This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Furuta, A. Articles by Martin, L. J. Search for Related Content PubMed PubMed Citation Articles by Furuta, A. Articles by Martin, L. J.

American Journal of Pathology, Vol 146, 357-367, Copyright © 1995 by American Society for Investigative Pathology

REGULAR ARTICLES

Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus

A Furuta, DL Price, CA Pardo, JC Troncoso, ZS Xu, N Taniguchi and LJ Martin
Neuropathology Laboratory, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Abnormalities in the cellular regulation and expression of antioxidant enzymes may have a role in mechanisms of central nervous system aging and neurodegeneration. We therefore examined, using isozyme-specific antibodies and immunohistochemistry, the localization of copper, zinc- superoxide dismutase and manganese-superoxide dismutase in the frontal and temporal neocortices and hippocampi of aged controls and individuals with Alzheimer's disease or Down's syndrome. Two different antibodies to copper, zinc-superoxide dismutase and one antibody to manganese-superoxide dismutase were evaluated by immunoblotting of homogenates of human brain before use in immunohistochemistry. The copper, zinc-superoxide dismutase antibodies recognized a single band of proteins at 16 kd. The manganese-superoxide dismutase antibody detected a single band of proteins at 25 kd. Immunohistochemically, copper, zinc-superoxide dismutase and manganese-superoxide dismutase immunoreactivities were localized predominantly to neocortical and hippocampal pyramidal neurons and scarcely seen in glial cells in controls. In Alzheimer's disease and Down's syndrome, the distributions and intensities of these two forms of superoxide dismutase immunoreactivities were different as compared with controls. Copper, zinc-superoxide dismutase was enriched in pyramidal neurons undergoing degeneration, whereas manganese-superoxide dismutase was more enriched in reactive astrocytes than in neurons. In senile plaques, copper, zinc- superoxide dismutase-positive globular structures were surrounded by astrocytes highly enriched in manganese-superoxide dismutase. By double label immunohistochemistry, some pyramidal neurons coexpressed superoxide dismutases and tau, and a few copper, zinc-superoxide dismutase-positive structures in senile plaques colocalized with tau. Amyloid cores, diffuse plaques, and microglia scarcely showed colocalization with superoxide dismutase-positive structures. The observed changes in the cellular localization of superoxide dismutases in neocortex and hippocampus in cases of Alzheimer's disease and Down's syndrome support a role for oxidative injury in neuronal degeneration and senile plaque formation. The differential localization of copper, zinc-superoxide dismutase and manganese-superoxide dismutase in cerebral sites of degeneration suggests that cellular responses to oxidative stress is antioxidant enzyme specific and cell type specific and that these two forms of superoxide dismutase may have different functions in antioxidant mechanisms.

This article has been cited by other articles:

				X.-K. Tong, N. Nicolakakis, A. Kocharyan, and E. Hamel Vascular Remodeling versus Amyloid {beta}-Induced Oxidative Stress in the Cerebrovascular Dysfunctions Associated with Alzheimer's Disease J. Neurosci., November 30, 2005; 25(48): 11165 - 11174. [Abstract] [Full Text] [PDF]

				J. Choi, H. D. Rees, S. T. Weintraub, A. I. Levey, L.-S. Chin, and L. Li Oxidative Modifications and Aggregation of Cu,Zn-Superoxide Dismutase Associated with Alzheimer and Parkinson Diseases J. Biol. Chem., March 25, 2005; 280(12): 11648 - 11655. [Abstract] [Full Text] [PDF]

				L. Liao, D. Cheng, J. Wang, D. M. Duong, T. G. Losik, M. Gearing, H. D. Rees, J. J. Lah, A. I. Levey, and J. Peng Proteomic Characterization of Postmortem Amyloid Plaques Isolated by Laser Capture Microdissection J. Biol. Chem., August 27, 2004; 279(35): 37061 - 37068. [Abstract] [Full Text] [PDF]

				M. Grundman Vitamin E and Alzheimer disease: the basis for additional clinical trials1 Am. J. Clinical Nutrition, February 1, 2000; 71(2): 630s - 636s. [Abstract] [Full Text] [PDF]

				N. Y. Calingasan, L. C. H. Park, L. L. Calo, R. R. Trifiletti, S. E. Gandy, and G. E. Gibson Induction of Nitric Oxide Synthase and Microglial Responses Precede Selective Cell Death Induced by Chronic Impairment of Oxidative Metabolism Am. J. Pathol., August 1, 1998; 153(2): 599 - 610. [Abstract] [Full Text] [PDF]

				M. A. Pappolla, M. Sos, R. A. Omar, R. J. Bick, D. L. M. Hickson-Bick, R. J. Reiter, S. Efthimiopoulos, and N. K. Robakis Melatonin Prevents Death of Neuroblastoma Cells Exposed to the Alzheimer Amyloid Peptide J. Neurosci., March 1, 1997; 17(5): 1683 - 1690. [Abstract] [Full Text] [PDF]

				S. Huggle, J. C. Hunsaker, C. M. Coyne, and D. L. Sparks Oxidative Stress in Sudden Infant Death Syndrome J Child Neurol, November 1, 1996; 11(6): 433 - 438. [Abstract] [PDF]

				K. Sugaya, M. Chouinard, R. Greene, M. Robbins, D. Personett, C. Kent, M. Gallagher, and M. McKinney Molecular Indices of Neuronal and Glial Plasticity in the Hippocampal Formation in a Rodent Model of Age-Induced Spatial Learning Impairment J. Neurosci., May 15, 1996; 16(10): 3427 - 3443. [Abstract] [Full Text] [PDF]